Support Groups
Connect with others who share similar health concerns.Get started now...Health savings
Get more than $250 in savings from your favorite brands. Get started now...Find a doctor
Search over 600,000 physicians and dentists nationwide. Get started now...Symptom Checker
Find out what your symptoms could mean. Get started now...
ADVERTISEMENT
Drug prevents bone loss in prostate cancer - Amgen
CHICAGO (Reuters) - Amgen Inc on Monday said that a trial of its experimental drug denosumab showed that it can prevent osteoporosis in men being treated with prostate cancer drugs that can cause bone loss. The three-year study of more than 1,400 men with non-metastatic prostate cancer undergoing androgen deprivation therapy showed denosumab produced greater increases in bone mineral density at the lumbar spine and non-vertebral sites than a placebo. Men receiving denosumab also experienced less than half the incidence of new vertebral fractures than those receiving the placebo, Amgen said. Both findings were statistically significant, it said.
Copyright © 2008 MTS Corp, All rights reserved.
ADHD Treatments | Allergy Treatments | Alzheimer's Treatment | Anxiety Symptoms | Arthritis Symptoms | Asthma | Bipolar Disorder Treatments | Blood Pressure Symptoms | Breast Cancer | Cancer Support | Depression | Diabetes Treatments | Flu Symptoms | GERD Symptoms | GERD Treatments | Heartburn Symptoms | Heartburn Treatments | Hypertension Symptoms | Incontinence Treatments | Insomnia Treatments | Menopause Symptoms | Migraine Symptoms | Obesity Treatments | Osteoarthritis Symptoms | Parkinson's Symptoms | Psoriasis Symptoms | Rheumatoid Arthritis Symptoms | Schizophrenia Symptoms
Resources & Tools:
Ask Your Doctor | Exams & Tests | Health Encyclopedia | Nutrition | Recipes | Symptom Checker



